home.aspx
 
EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

SiriusDecisions Roadshow New York
SIRIUSDECISIONS ROADSHOW NEW YORK
September 10-10, 2019
The future of the b-to-b buyer experience: Account-based, digital and human. Marketing and sales have a new challenge in b-to-b: How to transform the power of technology into a compelling experience that’s online and automated but also personal and meaningful. Learn what high performing compan...

SiriusDecisions

SiriusDecisions® is the leading global b-to-b research and advisory firm. We deliver actionable intelligence, strategic and operational frameworks, and personal guidance from experienced practitioners. Sales, marketing and product executives rely on SiriusDecisions® to contextualize problems and bring to light opportunities to drive sustainable growth. Our holistic solutions are founded on proprietary research, a deep understanding of b-to-b complexities, and the tenet that organizational alignment brings better outcomes.

RELATED NEWS


Environmental conditions influence our body mass index (BMI) by increasing or decreasing the effect of inherited genetic variations, University of Queensland researchers have discovered. A team led by Huanwei Wang and Professor Jian Yang from UQs Institute for Molecular Bioscience found the opposite for human height that the genetic effects that influence it are very stable from one environment to another. The discovery could help determine whether, for any particular traits, the effect of a gen...

READ MORE

Chinas theft of intellectual property from the U.S. and other countries isnt new remember the Genentech scientists and the GlaxoSmithKline researchers who funneled trade secrets to associates in China and Taiwan? But a government crackdown to counter theft has highlighted another threat, one that could damage U.S. leadership in the life sciences. Recently, some scientists from China, or American-born of Chinese heritage, have been summarily dismissed from their university positions, creating a c...

READ MORE

Pfizer will expand its manufacturing of gene therapies in North Carolina, where the pharma giant joined Gov. Roy Cooper in announcing plans for a 500 million dollars facility expansion in Sanford that is expected to add 300 jobs to its local workforce of 650. The planned expansion which will grow its Sanford workforce by nearly 50 Percent comes three years to the month that Pfizer expanded into gene therapy by acquiring Bamboo Therapeutics for up to 645 million dollars. The following year, Pfize...

READ MORE

The twitch of a butterflys wing can initiate a cascade of increasingly substantial events, culminating in changes that are both profound and far-reaching. Thats the gist of any butterfly effect, whether its the formation of hurricane, the climax of a Hollywood movie, or the differentiation of a stem cell. A stem cells fate, it turns out, can hinge on a single protein, one that stays in telomeres but accounts for genome-wide changes. The protein, telomer repeat binding factor 1 TRF1, may twitch o...

READ MORE

NuCana pulled off its 100 million dollars Nasdaq debut on the promise of its reformulated cancer meds, including a version of Eli Lillys Gemzar the company hopes will replace the veteran chemotherapy in some cancers. But that drug has hit a snag in its lead indication- pancreatic cancer. The cancer center carrying out a phase 3 study in metastatic pancreatic cancer has stopped enrolling patients after an independent committee deemed the trial unlikely to succeed. The site had recruited 200 patie...

READ MORE

Most types of Escherichia coli are harmless, but the ones that arent can cause severe life threatening diarrhea. These problematic bacteria launch infections by inducing intestinal cells to form tiny structures pedestals that anchor the pathogens in place and help the colonies grow. Now, researchers report in mBio Pathogenic Escherichia coli Hijacks GTPase-Activated p21-Activated Kinase for Actin Pedestal Formation that they have discovered an Achilles heel for disabling pedestal formation. Lab ...

READ MORE

Lionbridge, the world's most trusted global communications platform, is pleased to announce that it has won the Technology division award for Employee Engagement in the Conference Board's Excellence in Marketing & Communications Awards Program. This prestigious program honors organizations for their innovative use of communications technologies. Last year, Lionbridge developed a new intranet known as The Bridge to help its more than 6,000 employees around the world live out its missi...
SOURCE
READ MORE

Lionbridge Technologies is proud to announce it has again been named one of America's Best Employers by Forbes, which also recognized Lionbridge as a Best Employer for Women in 2018. The 2019 list recognizes organizations across a variety of industries that employ more than 1,000 people in the U.S. Working with Statista, Forbes deployed an independent survey to a representative sample of the US workforce and reached more than 50,000 employees overall. The rankings were mainly assessed based ...
SOURCE
READ MORE

The Pfizer Foundation has awarded 20 grants to organizations involved in tackling infectious diseases in low- and middle-income countries. Pfizer set up the foundation to promote access to healthcare and nurture innovation. As part of that focus, the nonprofit has selected 20 organizations in 12 countries to receive one-year grants worth 100,000 Dollars, resulting in a total outlay of 2 million dollars. The recipients of the grants are involved in tackling infectious diseases, including initiati...

READ MORE

The FDA dealt a surprise rejection to Sarepta Therapeutics Monday, telling the company in a Complete Response Letter CRL that it was passing its second Duchenne muscular dystrophy DMD drug over due to risks of infusion port infection and kidney toxicity seen in animal studies. Sareptas first move will be to meet with the FDA to negotiate a black box warning or other labeling for the drug, golodirsen, to spell out the risk of kidney toxicity and infection risk, rather than to carry out more studi...

READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

SiriusDecisions Roadshow New York
SIRIUSDECISIONS ROADSHOW NEW YORK
September 10-10, 2019
The future of the b-to-b buyer experience: Account-based, digital and human. Marketing and sales have a new challenge in b-to-b: How to transform the power of technology into a compelling experience that’s online and automated but also personal and meaningful. Learn what high performing compan...